查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830801

2025年全球体外大肠直肠癌筛检市场报告

In-vitro Colorectal Cancer Screening Tests Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外大肠直肠癌筛检市场规模呈现强劲成长势头，从2024年的12.1亿美元增加至2025年的13亿美元，复合年增长率达7.4%。这一历史性增长可归因于人们对早期癌症检测认识的不断提高、政府筛检项目的扩展、非侵入性检测方法的日益普及、医疗保健支出的不断增长以及家用筛检套件的普及。

预计未来几年体外大肠直肠癌筛检市场将强劲成长，到2029年将达到17.1亿美元，复合年增长率为7.0%。预测期内的成长可归因于对个人化医疗的日益关注、对经济高效诊断方法的需求不断增长、癌症研究投资的不断扩大、分子诊断技术的日益普及、结直肠癌患病率的上升以及新兴市场检测可及性的提高。预测期内的主要趋势包括液态切片技术的进步、生物标记发现的创新、人工智慧在检测分析中的整合、多目标粪便去氧核糖核酸检测的开发、样本采集和处理的创新、自动化和数位病理学的进步以及云端基础诊断平台的普及。

体外大肠直肠癌筛检是一种非侵入性的实验室检测，透过检查粪便或血液样本来识别大肠直肠癌和癌前病变的指标。这些检测能够在无症状个体中早期发现大肠直肠癌，从而促进及时干预并降低癌症相关死亡率。

体外大肠直肠癌筛检测试的主要类型包括大便潜血试验、粪便去氧核糖核酸(DNA) 测试和血液生物标记测试。大便潜血试验是一种非侵入性诊断方法，用于检测粪便中的隐藏（潜血），这可能表明早期大肠直肠癌或其他胃肠道疾病。各种影像诊断技术，包括大肠镜检查、肛门镜检查、电脑断层扫描 (CT)、超音波、超音波磁振造影(MRI) 和正子断层扫描 (PET)，支援广泛的应用，包括筛检、诊断、监测、风险评估和治疗后监测。这些测试和技术服务于各种最终用户，包括医院、诊断实验室、门诊、居家照护机构和研究机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦严重影响了医疗保健产业，尤其是关键医疗设备、诊断设备和药品的供应。医院和医疗机构面临进口手术器械、影像设备以及注射器和导管等消耗品成本上涨的问题。这些成本上涨给医疗保健预算带来了巨大压力，导致一些医疗机构推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税阻碍了基本药品和医疗设备的生产，造成了供应链瓶颈。为此，该行业正在筹资策略多元化，尽可能促进本地生产，并倡导对紧急医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供体外结直肠癌筛检筛检市场统计数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的体外结直肠癌筛检测试细分市场、市场趋势和机会，以及您在体外结直肠癌筛检测试行业取得成功所需的数据。本体外结直肠癌筛检测试市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

预计未来几年，大肠直肠癌盛行率的上升将推动试管内肠癌筛检市场的成长。大肠直肠癌是一种发生于结肠或直肠的癌症，通常由癌前息肉发展而来。大肠直肠癌发生率的上升很大程度上与不健康的生活方式有关，因为不良饮食、缺乏运动和肥胖会增加息肉形成和癌症发展的风险。试管内结直肠癌筛检试验透过提供一种非侵入性方法，在早期阶段检测癌症，从而支持早期诊断。这些试验透过先进的生物标记检测提高了筛检的准确性，从而能够及时干预并改善患者预后。例如，根据美国非营利组织美国癌症协会的数据，预计2025年2月结直肠癌新病例数将从2024年的152,810例增加到154,270例。因此，大肠直肠癌发生率的上升刺激了试管内直肠癌筛检测试市场的扩张。

试管内肠癌筛检市场的公司正专注于开发先进的诊断解决方案，例如多目标粪便 DNA 检测，以提高早期发现率、方便患者并降低大肠癌死亡率。多目标粪便 DNA 检测是一种创新的筛检工具，可分析粪便样本中与大肠癌和癌前病变相关的基因和生化标记。例如，2025 年 3 月，美国分子诊断公司 Exact Sciences Corp. 推出了 Cologuard Plus，这是一款针对 45 岁及以上平均风险成年人的增强型家用大肠癌筛检测试。该测试结合了先进的生物标记技术，比传统测试具有更高的灵敏度和特异性。该测试使用复杂的演算法来检测 DNA 突变和血红蛋白生物标记物，从而提高了大肠直肠癌和晚期腺瘤的检测率。 Cologuard Plus 提供了一种非侵入性且便捷的筛检选项，无需使用抗肠道药物或饮食限制，从而提高了患者对建议筛检指南的依从性。

2025年2月，德国生技公司Mainz Biomed NV与Labor Team W AG合作推出ColoAlert。此次合作旨在利用Labor Team W AG的诊断网络，并扩大ColoAlert在瑞士全境的覆盖范围，从而提高大肠直肠癌的早期发现率，并改善患者预后。 Labor Team W AG是一家总部位于瑞士的诊断服务公司，专注于体外大肠癌筛检。

体外结直肠癌筛检测试市场由提供分子诊断测试、实验室样本采集和处理服务、风险评估和遗传咨询服务、远端医疗医疗筛检咨询、医疗营业单位筛检专案管理以及电子健康记录(EHR) 整合服务等服务的实体所获得的收入组成。市场价值包括服务提供者销售的或包含在其服务产品中的任何相关产品的收益。试管内大肠直肠癌筛检测试市场还包括样本采集设备、自动筛检设备、样本储存和运输系统以及数位诊断平台的销售。该市场的价值是“出厂价”，即产品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的产品价值。该市场中的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球体外大肠直肠癌筛检测试：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球体外大肠直肠癌筛检测试市场：成长率分析
  • 全球体外大肠直肠癌筛检测试市场表现：规模与成长，2019-2024
  • 全球体外大肠直肠癌筛检测试市场预测：规模与成长，2024-2029年，2034年
  • 全球体外大肠直肠癌筛检测试：总目标市场（TAM）

第六章 市场细分

  • 全球体外大肠直肠癌筛检市场（按检测类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 大便潜血试验
  • 粪便去氧核糖核酸检测
  • 血液生物标记检测
  • 其他测试类型
  • 全球体外大肠直肠癌筛检市场（按影像类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 大肠镜检查
  • 直肠镜检查
  • 电脑断层扫描
  • 超音波
  • 磁振造影
  • 正子断层扫描
  • 全球体外大肠直肠癌筛检市场：应用、绩效及预测（2019-2024年、2024-2029年及2034年）
  • 筛检
  • 诊断
  • 监控
  • 风险评估
  • 治疗后监测
  • 全球体外大肠直肠癌筛检市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断实验室
  • 门诊
  • 居家照护环境
  • 研究机构
  • 全球体外大肠直肠癌筛检测试市场：粪便大便潜血试验细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 癒创木脂大便潜血试验
  • 免疫化学大便潜血试验
  • 全球体外大肠直肠癌筛检测试市场：粪便去氧核糖核酸检测细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单项粪便去氧核糖核酸检测
  • 多目标粪便去氧核糖核酸检测
  • 全球体外大肠直肠癌筛检测试市场：依血液生物标记测试（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 甲基化septin 9去氧核糖核酸检测
  • 循环肿瘤去氧核糖核酸检测
  • 基于蛋白质生物标记的血液检测
  • 全球体外大肠直肠癌筛检测试市场：依测试类型（其他）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 尿液生物标记检测
  • 基于血清的生物标记检测
  • 呼吸挥发性有机化合物测试

第七章 区域和国家分析

  • 全球体外大肠直肠癌筛检检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球体外大肠癌筛检市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 体外大肠直肠癌筛检测试市场：竞争格局
  • 体外大肠直肠癌筛检测试市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Exact Sciences Corporation
  • Natera Inc.
  • Leica Biosystems Nussloch GmbH
  • BGI Genomics Co. Ltd.
  • NeoGenomics Inc.
  • Guardant Health Inc.
  • CellMax Life Inc.
  • Epigenomics AG
  • Acuamark Diagnostics Inc.
  • Beacon Biomedical Inc.
  • Mainz Biomed NV

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年体外大肠直肠癌筛检测试市场：提供新机会的国家
  • 2029年体外大肠直肠癌筛检测试市场：细分市场带来新机会
  • 2029年体外大肠直肠癌筛检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37790

In-vitro colorectal cancer screening tests are non-invasive, laboratory-based tests that examine stool or blood samples to identify indicators of colorectal cancer or precancerous conditions. These tests enable early detection of colorectal cancer in asymptomatic individuals, facilitating timely intervention and reducing cancer-related mortality.

The primary types of in-vitro colorectal cancer screening tests include the fecal occult blood test, stool deoxyribonucleic acid (DNA) test, blood biomarker test, and others. The fecal occult blood test is a non-invasive diagnostic method used to detect hidden (occult) blood in the stool, which may indicate early colorectal cancer or other gastrointestinal disorders. Various imaging techniques, including colonoscopy, proctoscopy, computed tomography (CT) scans, ultrasound, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans, support a wide range of applications such as screening, diagnosis, monitoring, risk assessment, and post-treatment surveillance. These tests and techniques serve a variety of end users, including hospitals, diagnostic laboratories, outpatient clinics, home care settings, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The in-vitro colorectal cancer screening tests market research report is one of a series of new reports from The Business Research Company that provides in-vitro colorectal cancer screening tests market statistics, including in-vitro colorectal cancer screening tests industry global market size, regional shares, competitors with a in-vitro colorectal cancer screening tests market share, detailed in-vitro colorectal cancer screening tests market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro colorectal cancer screening tests industry. This in-vitro colorectal cancer screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro colorectal cancer screening tests market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to rising awareness of early cancer detection, the expansion of government screening programs, increased adoption of non-invasive testing methods, growing healthcare expenditure, and greater availability of at-home screening kits.

The in-vitro colorectal cancer screening tests market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth during the forecast period can be attributed to an increasing focus on personalized medicine, rising demand for cost-effective diagnostics, growing investments in cancer research, expanding adoption of molecular diagnostic techniques, increasing prevalence of colorectal cancer, and greater accessibility of testing in emerging markets. Major trends expected in the forecast period include advancements in liquid biopsy technologies, innovations in biomarker discovery, integration of artificial intelligence in test analysis, development of multi-target stool deoxyribonucleic acid tests, innovations in sample collection and processing, progress in automation and digital pathology, and the adoption of cloud-based diagnostic platforms.

The rising prevalence of colorectal cancer is expected to drive growth in the in vitro colorectal cancer screening tests market in the coming years. Colorectal cancer is a type of cancer that originates in the colon or rectum, often developing from precancerous polyps. The increasing incidence of colorectal cancer is largely linked to unhealthy lifestyle habits, as poor diet, physical inactivity, and obesity elevate the risk of polyp formation and cancer development. In vitro colorectal cancer screening tests support early diagnosis by providing non-invasive methods to detect cancer at initial stages. These tests enhance screening accuracy through advanced biomarker detection, enabling timely intervention and improved patient outcomes. For example, in February 2025, according to the American Cancer Society, a US-based nonprofit organization, the estimated number of new colorectal cancer cases reached 154,270, up from 152,810 cases in 2024. Therefore, the rising prevalence of colorectal cancer is fueling the expansion of the in vitro colorectal cancer screening tests market.

Companies in the in vitro colorectal cancer screening tests market are focusing on developing advanced diagnostic solutions, such as multi-target stool DNA tests, to improve early detection, enhance patient convenience, and reduce colorectal cancer mortality. Multi-target stool DNA tests are innovative screening tools that analyze stool samples for genetic and biochemical markers linked to colorectal cancer and precancerous lesions. For instance, in March 2025, Exact Sciences Corp., a US-based molecular diagnostics company, introduced Cologuard Plus, an enhanced at-home colorectal cancer screening test for average-risk adults aged 45 and older. This test incorporates advanced biomarker technology to deliver higher sensitivity and specificity than its predecessor. It uses a refined algorithm to detect DNA mutations and hemoglobin biomarkers, improving detection of both colorectal cancer and advanced adenomas. Cologuard Plus offers a non-invasive, convenient screening option that eliminates the need for bowel preparation or dietary restrictions, thereby improving patient adherence to recommended screening guidelines.

In February 2025, Mainz Biomed N.V., a Germany-based biotech company, partnered with Labor Team W AG to launch ColoAlert. This collaboration aims to expand the availability of ColoAlert across Switzerland, leveraging Labor Team W AG's diagnostic network to enhance early colorectal cancer detection and improve patient outcomes. Labor Team W AG is a Switzerland-based diagnostic services company specializing in in vitro colorectal cancer screening tests.

Major players in the in-vitro colorectal cancer screening tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Quest Diagnostics Incorporated, Roche Diagnostics International AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Natera Inc., Leica Biosystems Nussloch GmbH, BGI Genomics Co. Ltd., NeoGenomics Inc., Guardant Health Inc., CellMax Life Inc., Epigenomics AG, Acuamark Diagnostics Inc., Beacon Biomedical Inc., Mainz Biomed NV.

North America was the largest region in the in-vitro colorectal cancer screening tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in in-vitro colorectal cancer screening tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in-vitro colorectal cancer screening tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro colorectal cancer screening tests market consists of revenues earned by entities by providing services such as molecular diagnostic testing, lab sample collection and processing services, risk assessment and genetic counseling services, telehealth-based screening consultations, screening program management for institutions, and electronic health record (EHR) integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro colorectal cancer screening tests market also includes sales of sample collection devices, automated screening instruments, sample preservation and transport systems, and digital diagnostic platforms. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-vitro Colorectal Cancer Screening Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro colorectal cancer screening tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro colorectal cancer screening tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro colorectal cancer screening tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Fecal Occult Blood Test; Stool Deoxyribonucleic Acid Test; Blood Biomarker Test; Other Test Types
  • 2) By Imaging Type: Colonoscopy; Proctoscopy; Computed Tomography Scan; Ultrasound; Magnetic Resonance Imaging; Positron Emission Tomography Scan
  • 3) By Application: Screening; Diagnosis; Monitoring; Risk Assessment; Post-Treatment Surveillance
  • 4) By End User: Hospitals; Diagnostic Laboratories; Outpatient Clinics; Home Care Settings; Research Institutions
  • Subsegments:
  • 1) By Fecal Occult Blood Test: Guaiac Based Fecal Occult Blood Test; Immunochemical Fecal Occult Blood Test
  • 2) By Stool Deoxyribonucleic Acid Test: Single Target Stool Deoxyribonucleic Acid Test; Multi Target Stool Deoxyribonucleic Acid Test
  • 3) By Blood Biomarker Test: Methylated Septin 9 Deoxyribonucleic Acid Test; Circulating Tumor Deoxyribonucleic Acid Test; Protein Biomarker Based Blood Test
  • 4) By Other Test Types: Urine Based Biomarker Test; Serum Based Biomarker Test; Breath Based Volatile Organic Compound Test
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers; Quest Diagnostics Incorporated; Roche Diagnostics International AG; Illumina Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Qiagen N.V.; Exact Sciences Corporation; Natera Inc.; Leica Biosystems Nussloch GmbH; BGI Genomics Co. Ltd.; NeoGenomics Inc.; Guardant Health Inc.; CellMax Life Inc.; Epigenomics AG; Acuamark Diagnostics Inc.; Beacon Biomedical Inc.; Mainz Biomed NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-vitro Colorectal Cancer Screening Tests Market Characteristics

3. In-vitro Colorectal Cancer Screening Tests Market Trends And Strategies

4. In-vitro Colorectal Cancer Screening Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In-vitro Colorectal Cancer Screening Tests Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In-vitro Colorectal Cancer Screening Tests PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In-vitro Colorectal Cancer Screening Tests Market Growth Rate Analysis
  • 5.4. Global In-vitro Colorectal Cancer Screening Tests Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In-vitro Colorectal Cancer Screening Tests Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In-vitro Colorectal Cancer Screening Tests Total Addressable Market (TAM)

6. In-vitro Colorectal Cancer Screening Tests Market Segmentation

  • 6.1. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fecal Occult Blood Test
  • Stool Deoxyribonucleic Acid Test
  • Blood Biomarker Test
  • Other Test Types
  • 6.2. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colonoscopy
  • Proctoscopy
  • Computed Tomography Scan
  • Ultrasound
  • Magnetic Resonance Imaging
  • Positron Emission Tomography Scan
  • 6.3. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening
  • Diagnosis
  • Monitoring
  • Risk Assessment
  • Post-Treatment Surveillance
  • 6.4. Global In-vitro Colorectal Cancer Screening Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Outpatient Clinics
  • Home Care Settings
  • Research Institutions
  • 6.5. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Fecal Occult Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guaiac Based Fecal Occult Blood Test
  • Immunochemical Fecal Occult Blood Test
  • 6.6. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Target Stool Deoxyribonucleic Acid Test
  • Multi Target Stool Deoxyribonucleic Acid Test
  • 6.7. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Blood Biomarker Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Methylated Septin 9 Deoxyribonucleic Acid Test
  • Circulating Tumor Deoxyribonucleic Acid Test
  • Protein Biomarker Based Blood Test
  • 6.8. Global In-vitro Colorectal Cancer Screening Tests Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Based Biomarker Test
  • Serum Based Biomarker Test
  • Breath Based Volatile Organic Compound Test

7. In-vitro Colorectal Cancer Screening Tests Market Regional And Country Analysis

  • 7.1. Global In-vitro Colorectal Cancer Screening Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In-vitro Colorectal Cancer Screening Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market

  • 8.1. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-vitro Colorectal Cancer Screening Tests Market

  • 9.1. China In-vitro Colorectal Cancer Screening Tests Market Overview
  • 9.2. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-vitro Colorectal Cancer Screening Tests Market

  • 10.1. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-vitro Colorectal Cancer Screening Tests Market

  • 11.1. Japan In-vitro Colorectal Cancer Screening Tests Market Overview
  • 11.2. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-vitro Colorectal Cancer Screening Tests Market

  • 12.1. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-vitro Colorectal Cancer Screening Tests Market

  • 13.1. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-vitro Colorectal Cancer Screening Tests Market

  • 14.1. South Korea In-vitro Colorectal Cancer Screening Tests Market Overview
  • 14.2. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-vitro Colorectal Cancer Screening Tests Market

  • 15.1. Western Europe In-vitro Colorectal Cancer Screening Tests Market Overview
  • 15.2. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-vitro Colorectal Cancer Screening Tests Market

  • 16.1. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-vitro Colorectal Cancer Screening Tests Market

  • 17.1. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-vitro Colorectal Cancer Screening Tests Market

  • 18.1. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-vitro Colorectal Cancer Screening Tests Market

  • 19.1. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-vitro Colorectal Cancer Screening Tests Market

  • 20.1. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market

  • 21.1. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market Overview
  • 21.2. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-vitro Colorectal Cancer Screening Tests Market

  • 22.1. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-vitro Colorectal Cancer Screening Tests Market

  • 23.1. North America In-vitro Colorectal Cancer Screening Tests Market Overview
  • 23.2. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-vitro Colorectal Cancer Screening Tests Market

  • 24.1. USA In-vitro Colorectal Cancer Screening Tests Market Overview
  • 24.2. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-vitro Colorectal Cancer Screening Tests Market

  • 25.1. Canada In-vitro Colorectal Cancer Screening Tests Market Overview
  • 25.2. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-vitro Colorectal Cancer Screening Tests Market

  • 26.1. South America In-vitro Colorectal Cancer Screening Tests Market Overview
  • 26.2. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-vitro Colorectal Cancer Screening Tests Market

  • 27.1. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-vitro Colorectal Cancer Screening Tests Market

  • 28.1. Middle East In-vitro Colorectal Cancer Screening Tests Market Overview
  • 28.2. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-vitro Colorectal Cancer Screening Tests Market

  • 29.1. Africa In-vitro Colorectal Cancer Screening Tests Market Overview
  • 29.2. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In-vitro Colorectal Cancer Screening Tests Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-vitro Colorectal Cancer Screening Tests Market Competitive Landscape And Company Profiles

  • 30.1. In-vitro Colorectal Cancer Screening Tests Market Competitive Landscape
  • 30.2. In-vitro Colorectal Cancer Screening Tests Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis

31. In-vitro Colorectal Cancer Screening Tests Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Sysmex Corporation
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Qiagen N.V.
  • 31.5. Exact Sciences Corporation
  • 31.6. Natera Inc.
  • 31.7. Leica Biosystems Nussloch GmbH
  • 31.8. BGI Genomics Co. Ltd.
  • 31.9. NeoGenomics Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. CellMax Life Inc.
  • 31.12. Epigenomics AG
  • 31.13. Acuamark Diagnostics Inc.
  • 31.14. Beacon Biomedical Inc.
  • 31.15. Mainz Biomed NV

32. Global In-vitro Colorectal Cancer Screening Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-vitro Colorectal Cancer Screening Tests Market

34. Recent Developments In The In-vitro Colorectal Cancer Screening Tests Market

35. In-vitro Colorectal Cancer Screening Tests Market High Potential Countries, Segments and Strategies

  • 35.1 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In-vitro Colorectal Cancer Screening Tests Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer